Relationships with Stakeholders and Shareholders.
The Board recognizes the importance of communication with its shareholders to ensure that its strategy and performance are understood and that it remains accountable to shareholders and we therefore maintain a regular dialogue with our institutional investors. This website has a dedicated investor section, which is fully compliant with AIM Rule 26 and provides useful information for our shareholders including the latest announcements, press releases, published financial information, details of our products and our current development pipeline and other information about the Company. The Board as a whole is responsible for ensuring that a satisfactory dialogue with shareholders takes place, while the Chief Executive Officer and Chairman ensure that the views of the shareholders are communicated to the Board as a whole. The Board ensures that our strategic plans have been carefully reviewed in terms of their ability to deliver long‑term shareholder value.
Shareholders are welcome to attend our AGM, where they have the opportunity to meet the Board. All shareholders will have at least 21 days’ notice of the AGM, at which directors will be available to discuss aspects of the Group’s performance and answer questions. The results of voting on all resolutions in future general meetings will be posted to the Group’s website, including any actions to be taken as a result of resolutions for which votes against have been received from at least 20 per cent of independent shareholders.
The Board understands the importance of social, environmental and ethical matters and it endeavors to take into account the differing interests of the Group’s stakeholders, including its investors, employees, patients, suppliers and business partners, when operating its business.
Never miss an update from Mereo. Sign up for and select the type of alerts you would like to receive by email.Register for Email Alerts
Share Price Information
Mereo is a specialty biopharma company developing innovative medicines for patients. Find out about our share price and latest trades.View Share Price